AMSBIO and Chondrex Cooperate On Arthritis & Inflammation Research
AMSBIO has announced a pan European partnership with Chondrex Inc. to market their high quality arthritis and inflammation reagents to academics and pharmaceutical companies that do research in these fields.
The range includes a suite of high quality reagents such as highly purified cartilage collagen and collagen monoclonal antibodies to provide scientists with the necessary tools to study the pathogenesis as well as to develop and screen potential therapeutics for Rheumatoid Arthritis (RA). In addition, AMSBIO has also improved its capability to provide reagents and various assay kits for the investigation of other important inflammatory diseases such as nephritis and allergic asthma.
Multi species Collagen reactive antibodies are available that can be used in western blotting, immunostaining and for inducing Collagen Antibody-Induced Arthritis (CAIA).
Collagenases, members of the matrix metalloproteinase (MMP) family, are involved in the physiological and pathological turnover of connective tissues. Collagenase production is significantly increased at the sites of inflammation due to the stimulation of pro-inflammatory cytokines. AMSBIO is now able to provide recombinant human MMP-8 and MMP-13, in addition to collagenase assay kits using FITC-labeled type I collagen and type II collagen, or a fluorogenic peptide as substrates. The new AMSBIO arthritis & inflammation research reagent range also includes type I and type II collagen specially purified for antibody assay by ELISA.
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous